The serum-based markers of liver function aspartate aminotransferase (AST) and alanine aminotransferase (ALT) and the ratio thereof correlated with an AD diagnosis, cognition, AD biomarkers and brain glucose metabolism in a large sample of participants of the AD Neuroimaging Initiative, and may therefore offer novel diagnostic and therapeutic opportunities [51]. The gene discussed is GPT; the disease is Alzheimer disease.